Inhibition of human cytomegalovirus DNA replication by small interfering RNAs targeted to UL49

Acta Biochimica et Biophysica Sinica

Volumn 45, Issue 5, 2013, Pages 401-407

  Wang, Kezhen ^a   Li, Yueqin ^a   Zhao, Gaoxiang ^a   Wu, Yingzi ^a   Zhang, Xin ^a   Li, Hongjian ^a   Zhou, Tianhong ^a  

^a JINAN UNIVERSITY   (China)

Author keywords

DNA replication; Human cytomegalovirus; siRNA; UL49

Indexed keywords

SMALL INTERFERING RNA; UL49 PROTEIN, HUMAN CYTOMEGALOVIRUS; VIRUS DNA; VIRUS PROTEIN;

ANIMAL; ARTICLE; BIOSYNTHESIS; CELL STRAIN COS1; CERCOPITHECUS; CYTOMEGALOVIRUS; CYTOMEGALOVIRUS INFECTION; DNA REPLICATION; DRUG ANTAGONISM; DRUG EFFECT; GENETICS; HUMAN; VIRUS REPLICATION;

ANIMALS; CERCOPITHECUS AETHIOPS; COS CELLS; CYTOMEGALOVIRUS; CYTOMEGALOVIRUS INFECTIONS; DNA REPLICATION; DNA, VIRAL; HUMANS; RNA, SMALL INTERFERING; VIRAL PROTEINS; VIRUS REPLICATION;

HUMAN HERPESVIRUS 5;

EID: 84879240179     PISSN: 16729145     EISSN: 17457270     Source Type: Journal    
DOI: 10.1093/abbs/gmt025     Document Type: Article

References (30)

1. Palella FJ, Jr, Delaney KM, Moorman AC, Loveless MO, Fuhrer J, Satten GA and Aschman DJ, et al. Declining morbidity and mortality among patients with advanced human immunodeficiency virus infection. HIV Outpatient Study Investigators. N Engl J Med 1998, 338: 853-860.
2. Gallant JE, Moore RD, Richman DD, Keruly J and Chaisson RE. Incidence and natural history of cytomegalovirus disease in patients with advanced human immunodeficiency virus disease treated with zidovudine. The Zidovudine Epidemiology Study Group. J Infect Dis 1992, 166: 1223-1227.
3. Demarchi JM. Human cytomegalovirus DNA: restriction enzyme cleavage maps and map locations for immediate-early, early, and late RNAs. Virology 1981, 114: 23-38.
4. McDonough SH and Spector DH. Transcription in human fibroblasts permissively infected by human cytomegalovirus strain AD169. Virology 1983, 125: 31-46.
5. Wathen MW, Thomsen DR and Stinski MF. Temporal regulation of human cytomegalovirus transcription at immediate early and early times after infection. J Virol 1981, 38: 446-459.
6. McVoy MA and Adler SP. Human cytomegalovirus DNA replicates after early circularization by concatemer formation, and inversion occurs within the concatemer. J Virol 1994, 68: 1040-1051.
7. Mocarski ES, Shenk T and Pass RT. Cytomegaloviruses. In: Knipe DM, Griffin DE, Lamb RA, Martin MA, Roizman B and Straus SE eds. Fields Virology. Vol. 2, 5th edn. Philadelphia: Lippincott Williams and Wilkins, 2007, 2701-2772.
8. Davison AJ, Dolan A, Akter P, Addison C, Dargan DJ, Alcendor DJ and McGeoch DJ, et al. The human cytomegalovirus genome revisited: comparison with the chimpanzee cytomegalovirus genome. J Gen Virol 2003, 84: 17-28.
9. Murphy E, Yu D, Grimwood J, Schmutz J, Dickson M, Jarvis MA and Hahn G, et al. Coding potential of laboratory and clinical strains of human cytomegalovirus. Proc Natl Acad Sci USA 2003, 100: 14976-14981.
10. Qian Z, Xuan B, Hong TT and Yu D. The full-length protein encoded by human cytomegalovirus gene UL117 is required for the proper maturation of viral replication compartments. J Virol 2008, 82: 3452-3465.
11. Scherer LJ and Rossi JJ. Approaches for the sequence-specific knockdown of mRNA. Nature Biotechnol 2003, 21: 1457-1465.
12. Stein CA and Cheng YC. Antisense oligonucleotides as therapeutic agents - is the bullet really magical? Science 1993, 261: 1004-1012.
13. zu Putlitz J, Yu Q, Burke JM and Wands Jr. Combinatorial screening and intracellular antiviral activity of hairpin ribozymes directed against hepatitis B virus. J Virol 1999, 73: 5381-5387.
14. Yu M, Ojwang J, Yamada O, Hampel A, Rapapport J, Looney D and Wong-Staal F. A hairpin ribozyme inhibits expression of diverse strains of human immunodeficiency virus type 1. Proc Natl Acad Sci U S A 1993, 90: 6340-6344.
15. Sarver N, Cantin EM, Chang PS, Zaia JA, Ladne PA, Stephens DA and Rossi JJ. Ribozymes as potential anti-HIV-1 therapeutic agents. Science 1990, 247: 1222-1225.
16. Wiebusch L, Truss M and Hagemeier C. Inhibition of human cytomegalovirus replication by small interfering RNAs. J Gene Virol 2004, 85: 179-184.
17. Jacque JM, Triques K and Stevenson M. Modulation of HIV-1 replication by RNA interference. Nature 2002, 418: 435-438.
18. Zhang W, Li H, Li Y, Zeng Z, Li S, Zhang X, Zou Y and Zhou T. Effective inhibition of HCMV UL49 gene expression and viral replication by oligonucleotide external guide sequences and RNase P. Virol J 2010, 7: 100.
19. Lee HR, Kim DJ, Lee JM, Choi CY, Ahn BY, Hayward GS and Ahn JH. Ability of the human cytomegalovirus IE1 protein to modulate sumoylation of PML correlates with its functional activities in transcriptional regulation and infectivity in cultured fibroblast cells. Jo Virol 2004, 78: 6527-6542.
20. Saffert RT and Kalejta RF. Human cytomegalovirus gene expression is silenced by Daxx-mediated intrinsic immune defense in model latent infections established in vitro. J Virol 2007, 81: 9109-9120.
21. Strang BL, Boulant S and Coen DM. Nucleolin associates with the human cytomegalovirus DNA polymerase accessory subunit UL44 and is necessary for efficient viral replication. J Virol 2010, 84: 1771-1784.
22. Mercer J, Snijder B, Sacher R, Burkard C, Bleck CK, Stahlberg H and Pelkmans L, et al. RNAi screening reveals proteasome- and cullin3- dependent stages in vaccinia virus infection. Cell Rep 2012, 2: 1036-1047.
23. Dittmer A and Bogner E. Specific short hairpin RNA-mediated inhibition of viral DNA packaging of human cytomegalovirus. FEBS lett 2006, 580: 6132-6138.
24. Yu D, Silva MC and Shenk T. Functional map of human cytomegalovirus AD169 defined by global mutational analysis. Proc Natl Acad Sci USA 2003, 100: 12396-12401.
25. Dunn W, Chou C, Li H, Hai R, Patterson D, Stolc V and Zhu H, et al. Functional profiling of a human cytomegalovirus genome. Proc Natl Acad Sci USA 2003, 100: 14223-14228.
26. Hannon GJ. RNA interference. Nature 2002, 418: 244-251.
27. Hutvagner G, McLachlan J, Pasquinelli AE, Balint E, Tuschl T and Zamore PD. A cellular function for the RNA-interference enzyme Dicer in the maturation of the let-7 small temporal RNA. Science 2001, 293: 834-838.
28. Salvant BS, Fortunato EA and Spector DH. Cell cycle dysregulation by human cytomegalovirus: influence of the cell cycle phase at the time of infection and effects on cyclin transcription. J Virol 1998, 72: 3729-3741.
29. Noris E, Zannetti C, Demurtas A, Sinclair J, De Andrea M, Gariglio M and Landolfo S. Cell cycle arrest by human cytomegalovirus 86-kDa IE2 protein resembles premature senescence. J Virol 2002, 76: 12135-12148.
30. Wiebusch L and Hagemeier C. Human cytomegalovirus 86-kilodalton IE2 protein blocks cell cycle progression in G(1). J Virol 1999, 73: 9274-9283.